Growth Metrics

Catalyst Pharmaceuticals (CPRX) Net Income Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 12.59%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -115.33%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -290.15%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 59.59%
7 Evaxion A 62.56 Bn 62.54 Bn - -73.01%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,228.66%
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn 12.33%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 12.33%
Dec 31, 2025 -1.18%
Sep 30, 2025 20.28%
Jun 30, 2025 27.73%
Mar 31, 2025 143.77%
Dec 31, 2024 172.80%
Sep 30, 2024 242.65%
Jun 30, 2024 8.03%
Mar 31, 2024 -21.28%
Dec 31, 2023 -50.26%
Sep 30, 2023 -235.24%
Jun 30, 2023 74.67%
Mar 31, 2023 123.31%
Dec 31, 2022 267.96%
Sep 30, 2022 120.23%
Jun 30, 2022 77.48%
Mar 31, 2022 72.79%
Dec 31, 2021 -18.61%
Sep 30, 2021 -76.17%
Jun 30, 2021 24.55%
Mar 31, 2021 -26.50%
Dec 31, 2020 44.24%
Sep 30, 2020 217.97%
Jun 30, 2020 -10.77%
Mar 31, 2020 1,717.68%
Dec 31, 2019 154.69%
Sep 30, 2019 273.88%
Jun 30, 2019 283.73%
Mar 31, 2019 88.69%
Dec 31, 2018 -169.12%
Sep 30, 2018 -87.64%
Jun 30, 2018 -53.74%
Mar 31, 2018 -14.75%
Dec 31, 2017 -29.41%
Sep 30, 2017 -5.66%
Jun 30, 2017 15.08%
Mar 31, 2017 7.78%
Dec 31, 2016 28.41%
Sep 30, 2016 11.13%
Jun 30, 2016 -0.23%
Mar 31, 2016 0.44%
Dec 31, 2015 -66.62%
Sep 30, 2015 11.19%
Jun 30, 2015 -42.54%
Mar 31, 2015 -41.96%
Dec 31, 2014 -157.63%
Sep 30, 2014 15.26%
Jun 30, 2014 -1.73%
Mar 31, 2014 -118.49%
Dec 31, 2013 -1,668.83%
Sep 30, 2013 -125.52%
Jun 30, 2013 -987.45%
Mar 31, 2013 -60.15%
Dec 31, 2012 96.74%
Sep 30, 2012 -132.44%
Jun 30, 2012 79.26%
Mar 31, 2012 28.21%
Dec 31, 2011 -222.73%
Sep 30, 2011 -24.76%